Last 12 months
Inside the activity.
0 purchase rows · 9 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 19, 2019 Filed Jun 21, 2019 20:16 UTC |
MARCUS JOEL SDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $21.28 | $0.00 |
DisclosureSEC source: 0000899243-19-017801 · doc4.xml · derivative · entry 1 MARCUS JOEL S · CIK 0001216955 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Ordinary Shares · 25,000 shares Expires 2029-06-19 F1 · derivative.exercise_date: The option shall vest and become exercisable in a single annual installment upon the earlier of (i) June 19, 2020 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2020. Read SEC document |
| May 09, 2019 Filed May 13, 2019 20:31 UTC |
Seligman NicoleDirector
|
GrantStock Option · Derivative | 50,000 | $0.00 Strike: $18.41 | $0.00 |
DisclosureSEC source: 0000899243-19-013232 · doc4.xml · derivative · entry 1 Seligman Nicole · CIK 0001683100 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Ordinary Shares · 50,000 shares Expires 2029-05-09 F1 · derivative.exercise_date: The option vests in 36 equal monthly installments following the date of grant. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 20:28 UTC |
Gottlieb BruceGeneral Counsel
|
GrantStock Option · Derivative | 200,000 | $0.00 Strike: $17.38 | $0.00 |
DisclosureSEC source: 0000899243-19-009571 · doc4.xml · derivative · entry 1 Gottlieb Bruce · CIK 0001772459 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Ordinary Shares · 200,000 shares Expires 2029-04-01 F1 · derivative.exercise_date: The option vests as to one quarter of the total grant on April 1, 2020 and vests as to the remainder in 36 equal monthly installments thereafter. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 22:22 UTC |
PERCEPTIVE ADVISORS LLC10% owner
EDELMAN JOSEPH10% owner
|
PurchaseOrdinary Shares | 1,304,348 | $13.80 | $18,000,002.40 |
DisclosureSEC source: 0001012975-19-000218 · edgar.xml · nonDerivative · entry 1 PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner PERCEPTIVE ADVISORS LLC · CIK 0001224962 · 10% owner EDELMAN JOSEPH · CIK 0001164426 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 6,007,746 F1 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 23:09 UTC |
Indyk MartinDirector
|
GrantStock Option · Derivative | 50,000 | $0.00 Strike: $12.81 | $0.00 |
DisclosureSEC source: 0000899243-19-004443 · doc4.xml · derivative · entry 1 Indyk Martin · CIK 0001766997 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Ordinary Shares · 50,000 shares Expires 2029-02-19 F1 · derivative.exercise_date: The option vests in 36 equal monthly installments following the date of grant. Read SEC document |
| December 29, 2018 Filed Jan 2, 2019 21:18 UTC |
Giroux RichardChief Operating Officer
|
GrantStock Option · Derivative | 105,000 | $0.00 Strike: $9.64 | $0.00 |
DisclosureSEC source: 0000899243-19-000118 · doc4.xml · derivative · entry 1 Giroux Richard · CIK 0001742734 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,000 Underlying: Ordinary Shares · 105,000 shares Expires 2028-12-29 F1 · derivative.exercise_date: The option vests as to one quarter of the total grant on December 29, 2019 and vests as to the remainder in 36 equal monthly installments thereafter. Read SEC document |
| December 29, 2018 Filed Jan 2, 2019 21:18 UTC |
Forbes AlexandriaDirector · President & CEO
|
GrantStock Option · Derivative | 130,000 | $0.00 Strike: $9.64 | $0.00 |
DisclosureSEC source: 0000899243-19-000117 · doc4.xml · derivative · entry 1 Forbes Alexandria · CIK 0001678604 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,000 Underlying: Ordinary Shares · 130,000 shares Expires 2028-12-29 F1 · derivative.exercise_date: The option vests as to one quarter of the total grant on December 29, 2019 and vests as to the remainder in 36 equal monthly installments thereafter. Read SEC document |
| December 29, 2018 Filed Jan 2, 2019 21:15 UTC |
Breedis KatherineChief Financial Officer
|
GrantStock Option · Derivative | 10,000 | $0.00 Strike: $9.64 | $0.00 |
DisclosureSEC source: 0000899243-19-000114 · doc4.xml · derivative · entry 1 Breedis Katherine · CIK 0001755082 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2028-12-29 F1 · derivative.exercise_date: The option vests as to one quarter of the total grant on December 29, 2019 and vests as to the remainder in 36 equal monthly installments thereafter. Read SEC document |
| December 29, 2018 Filed Jan 2, 2019 21:15 UTC |
Naylor StuartDirector · Chief Development Officer
|
GrantStock Option · Derivative | 100,000 | $0.00 Strike: $9.64 | $0.00 |
DisclosureSEC source: 0000899243-19-000113 · doc4.xml · derivative · entry 1 Naylor Stuart · CIK 0001742771 · Director · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Ordinary Shares · 100,000 shares Expires 2028-12-29 F1 · derivative.exercise_date: The option vests as to one quarter of the total grant on December 29, 2019 and vests as to the remainder in 36 equal monthly installments thereafter. Read SEC document |
| October 02, 2018 Filed Oct 4, 2018 20:16 UTC |
Breedis KatherineChief Financial Officer
|
GrantStock Option · Derivative | 40,000 | $0.00 Strike: $13.37 | $0.00 |
DisclosureSEC source: 0000899243-18-026205 · doc4.xml · derivative · entry 1 Breedis Katherine · CIK 0001755082 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Ordinary Shares · 40,000 shares Expires 2028-10-02 F1 · derivative.exercise_date: The option vests as to one quarter of the total grant on October 2, 2019 and vests as to the remainder in 36 equal monthly installments thereafter. Read SEC document |
| June 12, 2018 Filed Jun 12, 2018 20:05 UTC |
PERCEPTIVE ADVISORS LLCDirector · 10% owner
PERCEPTIVE LIFE SCIENCES MASTER FUND LTDDirector · 10% owner
EDELMAN JOSEPH10% owner
|
PurchaseOrdinary Shares | 1,333,333 | $15.00 | $19,999,995.00 |
DisclosureSEC source: 0001012975-18-000562 · edgar.xml · nonDerivative · entry 2 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Director · 10% owner EDELMAN JOSEPH · CIK 0001164426 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 4,703,398 F2 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| June 08, 2018 Filed Jun 12, 2018 20:05 UTC |
PERCEPTIVE ADVISORS LLCDirector · 10% owner
PERCEPTIVE LIFE SCIENCES MASTER FUND LTDDirector · 10% owner
EDELMAN JOSEPH10% owner
|
PurchaseOrdinary Shares | 50,000 | $15.22 | $761,000.00 |
DisclosureSEC source: 0001012975-18-000562 · edgar.xml · nonDerivative · entry 1 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Director · 10% owner EDELMAN JOSEPH · CIK 0001164426 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,370,065 F1 · price: The transaction was executed in multiple trades at prices ranging from $15.10 to $15.45. The price above reflects the weighted average price. Detailed information regarding the number of shares transacted at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer. F2 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.